1) terminal hepatic vein obliteration (THVO)
末端肝静脉闭塞
2) Hepatic veno-occlusive disease
肝小静脉闭塞病
1.
Pyrrolizidine alkaloids-containing plants and hepatic veno-occlusive disease;
含吡咯里西啶类生物碱植物与肝小静脉闭塞病
2.
There is lack of specific therapy to cure hepatic veno-occlusive disease(HVOD) up to now,the severe cases usually died from multiple organ failure,therefore it is pivotal to analyse the risk factors and diagnose early so as to rescue rapidly.
肝小静脉闭塞病(HVOD)缺乏特异治疗,重症患者常因多脏器功能衰竭而死亡,通过危险因素的分析有效避免其发生或在发病早期及时识别以早期干预至关重要。
3) Hepatic veno-occlusive disease
肝静脉闭塞病
1.
Prophylaxis of hepatic veno-occlusive disease after HSC transplantation with lipo-prostaglandin E1 plus dextran 40;
前列腺素E1脂质微球联合低分子右旋糖酐对造血干细胞移植后肝静脉闭塞病的预防作用分析
4) Veno-occlusive disease
肝小静脉闭塞病
1.
Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon;
中药土三七致肝小静脉闭塞病临床分析
2.
Two cases of Veno-Occlusive Disease and review;
肝小静脉闭塞病2例并文献复习
3.
Veno-occlusive disease is rare seen clinically, but recently disease rate is rising.
肝小静脉闭塞病临床上比较少见,近年来发病率逐渐增高。
5) Veno-occlusive disease
肝静脉闭塞病
1.
Diagnosis and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation
造血干细胞移植后肝静脉闭塞病的诊治
2.
BACKGROUND & OBJECTIVE: Veno-occlusive disease of the liver (VOD) is one of the most common complications in patients after hematopoietic stem cell transplantation (HSCT).
背景与目的:肝静脉闭塞病(veno-occlusive disease of the liver,VOD)是造血干细胞移植常见的并发症之一,重型VOD的病死率几乎达100%,目前VOD的预防和治疗仍较困难。
6) hepatic venular occlusive disease
肝小静脉闭塞症
1.
His abdominal CT scan showed evidence of hepatic venular occlusive disease.
CT表现符合肝小静脉闭塞症。
补充资料：肝静脉闭塞病
肝静脉闭塞病
venooclusive disease
肝中央静脉(终末肝静脉）内膜病变所致部分或完全闭塞引起的疾病。病因很多。最早牙买加报道因食用含有pyrrolizidine的千里光属植物及Crotal aria属植物所制的饮料引起。肝脏放射性损伤、酒精性肝损伤、某些抗癌药及免疫抑制药也可以诱发。病变主要引起肝终末静脉内膜水肿、细胞渗出、胶原化等。其周围肝细胞坏死、纤维化及充血。继续发展可形成充血性肝硬化。临床表现肝大、液体潴留、腹水、黄疸、腹痛和脑病等。确诊有赖于肝活检发现肝静脉病变。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条